PTSD and Trauma

Page 3

Recently published articles about PTSD and Trauma

JCP
Predictive Validity of Early Post-Injury CAPS-5 Score for Later PTSD Diagnosis
Original Research

August 5, 2024

A CAPS-5 score of ≥15 provided good predictive accuracy for subsequent PTSD development in the general injured population.
Jae-Min Kim, Ju-Wan Kim, Hee-Ju Kang, et al
Researchers Uncover How Psilocybin Works in the Brain
news

July 18, 2024

Psilocybin disrupts brain networks related to reflective thinking, offering potential therapeutic benefits for mental health issues.
Telehealth Usage Climbs While Payment Changes Threaten Care
news

July 16, 2024

Despite potential cost-sharing challenges, telehealth utilization, especially for mental health services, continues to grow nationally.
JCP
Effects of Low-Dose Ketamine Infusion on Hopelessness and Suicidal Thoughts
Original Research

July 8, 2024

A single infusion of low-dose ketamine resulted in a brief (~4 hour) yet significant reduction in hopelessness.
Wei-Chen Lin, Mu-Hong Chen, Tung-Ping Su, et al
PCC
Prazosin 3 Times Daily for PTSD-Induced Psychological Distress
Case Report

June 25, 2024

This report discusses utilization of a 3-times-daily prazosin dosing scheme during a hospital admission for a patient experiencing severe nightmares and daytime flashbacks associated with PTSD.
Kendall J. Tucker, Trisha T. Villanueva, Miles Fletcher, et al
JCP
Immune Targeted Therapies for Depression: Antidepressant Effects of Monoclonal Antibodies
Narrative Review

June 24, 2024

Immune dysregulation may contribute to treatment resistance in depression. Monoclonal antibodies have shown promise in treating depression when used for inflammatory disorders and may offer new hope for patients...
Mina M. Rizk, Lindsay Bolton, Flurin Cathomas, et al
9/11 First Responders Have Ninefold Increased Early Dementia Risk
news

June 13, 2024

WTC first responders who were heavily exposed to toxins have a significantly higher rate of early-onset dementia.
Weekly Mind Reader: Sleep Studies Reveal Suicide Risk Indicators
news

June 7, 2024

In this edition of the Weekly Mind Reader, we share commentary that digs into a bevy of studies that link sleep disorders and suicide.
Why FDA Panel Rejected MDMA for PTSD Treatment
news

June 5, 2024

An FDA advisory panel voted against the use of MDMA – or ecstasy – to treat post-traumatic stress disorder.
JCP
Accounting for Differences in Incident Guideline Discordant Prescribing for PTSD Among Women and Men Veterans
Original Research

June 5, 2024

Women Veterans with PTSD were 67% more likely to initiate a guideline discordant medication. More than half of this effect was explained by bipolar disorder, age, and prior psychiatric...
Kenda R. Stewart Steffensmeier, Katherine Hadlandsmyth, Nancy Bernardy, et al
JCP
The Long Road Toward Equitable MDMA Treatment in the United States
Commentary

May 29, 2024

Kozak and Aaronson discuss challenges in implementation of MDMA-assisted therapy, including insurance and Medicare coverage as well as cultural barriers.
Zofia Kozak, Scott T. Aaronson
JCP
Interpersonal Psychotherapy for PTSD: A Critical Review
Review Article

May 29, 2024

This critical review will give clinicians confidence in considering IPT as an alternative to exposure treatments for posttraumatic stress disorder.
John C. Markowitz

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe